Close navigation

Palliative Care

The Brain Tumour Charity, in partnership with Marie Curie Research UK (CRUK), Chief Scientist Office (CSO) in Scotland and the Motor Neurone Disease (MND) Association, is making over £1.25 million available in 2017 through the Marie Curie Research Grants Scheme.

The scheme funds high quality research to improve the quality of life of people with brain tumours and terminal illnesses, and their families, friends, carers and communities.

Application Process

There's a two stage application process for the Research Grants Scheme.

  • Stage one – outline application stage: we invite applicants to submit outlines of their proposed research projects to be considered by our experts.
  • Stage two – full application stage: we invite successful outline candidates to submit full applications via the Marie Curie Grants Management System (Gems), and notify applicants of the outcome.

Key Dates:

Tuesday, 25th September, 2018 - Call opens for outline applications

Monday, 10th December, 2018 (5:00 pm, GMT) - Call closes for outline applications

Spring 2019 - Outline application panel meeting

Spring 2019 - Successful outline applicants invited to full application stage

Summer 2019 - Deadline for full applications

Autumn 2019 - Deadline for applicants to respond to peer reviews

Autumn 2019 - Research Funding Committee meeting

Winter 2019 - Applicants notified of outcome


Applicants will be expected to outline how their application will address the following funding criteria for this call (within the defined word limits):

  • The potential to improve care and support for people living with a terminal illness and their families, friends, carers and communities.
  • Evidence of a demonstrable need for research in this area. Please highlight any relevant systematic reviews and/or all past/current trials, if applicable.
  • A clear research plan and description of methodology to be employed. For feasibility studies, include the outcome measures and describe how and from whom the full trial could be funded (e.g. the National Institute for Health Research).
  • The suitability of the PI(s), research team and collaborators to carry out the proposed research, including their track record and expertise. Please also include the involvement of any Clinical Trials Unit(s), if applicable.
  • The active engagement of Patient & Public Involvement (PPI) principles and processes in all stages of the research from planning through to dissemination.
  • The potential of study results or interventions to be generalisable and applicable nationally and/or internationally.
  • A dissemination and knowledge transfer plan, including and beyond peer reviewed publications

Further information about the scheme is available on the Marie Curie website.